Gene · 833
Papers4,113
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 4,113
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Determination of CAR T cell metabolism in an optimized protocol. | Front Bioeng Biotechnol | 2023 | 37409169 | PubTator, text mining | PubMed |
| Serum myoglobin modulates kidney injury via inducing ferroptosis after exertional heatstroke. | J Transl Int Med | 2023 | 37408574 | PubTator, text mining | PubMed |
| A phase 2 trial of defibrotide for the prevention of chimeric antigen receptor T-cell-associated neurotoxicity syndrome. | Blood Adv | 2023 | 37399456 | PubTator, text mining | PubMed |
| Limited efficacy of APRIL CAR in patients with multiple myeloma indicate challenges in the use of natural ligands for CAR T-cell therapy. | J Immunother Cancer | 2023 | 37399355 | PubTator, text mining | PubMed |
| Recent advances in treatment of nodal and gastrointestinal follicular lymphoma. | World J Gastroenterol | 2023 | 37398889 | PubTator, text mining | PubMed |
| Editorial: T-cell directed therapies in multiple myeloma. | Front Oncol | 2023 | 37397395 | PubTator, text mining | PubMed |
| CAR-T cells neurotoxicity from consolidated practice in hematological malignancies to fledgling experience in CNS tumors: fill the gap. | Front Oncol | 2023 | 37397356 | PubTator, text mining | PubMed |
Transcranial direct current stimulation to facilitate neurofunctional rehabilitation in children with autism spectrum disorder: a protocol for a randomized, sham-controlled, double-blind clinical trial. | Front Neurol | 2023 | 37396775 | PubTator, text mining | PubMed |
| Imaging the Side Effects of CAR T Cell Therapy: A Primer for the Practicing Radiologist. | Acad Radiol | 2023 | 37394411 | PubTator, text mining | PubMed |
| Long-term phonemic representations become audiovisual by mid-childhood. | Neuropsychologia | 2023 | 37394134 | PubTator, text mining | PubMed |
| Enrichment strategies to enhance genome editing. | J Biomed Sci | 2023 | 37393268 | PubTator, text mining | PubMed |
| CAR T cells as micropharmacies against solid cancers: Combining effector T-cell mediated cell death with vascular targeting in a one-step engineering process. | Cancer Gene Ther | 2023 | 37391502 | PubTator, text mining | PubMed |
| Emerging advances in nanobiomaterials-assisted chimeric antigen receptor (CAR)-macrophages for tumor immunotherapy. | Front Bioeng Biotechnol | 2023 | 37388769 | PubTator, text mining | PubMed |
| Boolean logic in synthetic biology and biomaterials: Towards living materials in mammalian cell therapeutics. | Clin Transl Med | 2023 | 37386762 | PubTator, text mining | PubMed |
| Synthetic Cell-Based Immunotherapies for Neurologic Diseases. | Neurol Neuroimmunol Neuroinflamm | 2023 | 37385738 | PubTator, text mining | PubMed |
| Fecal microbiota transplantation in hematopoietic cell transplant and cellular therapy recipients: lessons learned and the path forward. | Gut Microbes | 2023 | 37382423 | PubTator, text mining | PubMed |
| Treatment Refractoriness in Chronic Lymphocytic Leukemia: Old and New Molecular Biomarkers. | Int J Mol Sci | 2023 | 37373521 | PubTator, text mining | PubMed |
| Clinical Potential of Hydrogen Sulfide in Peripheral Arterial Disease. | Int J Mol Sci | 2023 | 37373103 | PubTator, text mining | PubMed |
| Insulin-Degrading Enzyme Interacts with Mitochondrial Ribosomes and Respiratory Chain Proteins. | Biomolecules | 2023 | 37371470 | PubTator, text mining | PubMed |
| Recent Advances in CAR-Based Solid Tumor Immunotherapy. | Cells | 2023 | 37371075 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/833/papers?page=27